Evidence map›Paper›PMID 37038467›Full record

ArticleHemaSphere2023

Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.

Wendy B C Stevens, G Tjitske Los-de Vries, Carole Langois-Jacques, Andrew J Clear, Phylicia Stathi, Birgitta Sander, Andreas Rosenwald, Maria Calaminici, Eva Hoster, Wolfgang Hiddemann and 21 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Wendy B C StevensDepartment of Hematology, Radboud UMC Nijmegen, the Netherlands.
G Tjitske Los-de VriesDepartment of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands.
Carole Langois-JacquesUniversité Lyon 1, Villeurbanne, France.
Andrew J ClearCentre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, United Kingdom.
Phylicia StathiDepartment of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands.
Birgitta SanderDivision of Pathology, Department of Laboratory Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
Andreas RosenwaldInstitute of Pathology, University of Würzburg, Germany.
Maria CalaminiciCentre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, United Kingdom.
Eva HosterInstitute for Medical Information Processing, Biometry, and Epidemiology (IBE), LMU University, Munich, Germany.
Wolfgang HiddemannDepartment of Medicine III, LMU University Hospital, Munich, Germany.
Philippe GaulardDepartment of Pathology, Henri Mondor University Hospital, APHP, INSERM U955, Université Paris-Est, Créteil, France.
Gilles SallesDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
Wolfram KlapperInstitute of Pathology, University of Schleswig-Holstein, Kiel, Germany.
Luc XerriDépartement de Biopathologie, Institut Paoli-Calmettes, Marseille, France.
Catherine BurtonHaematological Malignancy Diagnostic Service, St James University Hospital, Leeds, United Kingdom.
Reuben M ToozeDivision of Haematology & Immunology, Leeds Institute of Medical Research, University of Leeds, United Kingdom.
Alexandra G SmithEpidemiology & Cancer Statistics Group, Department of Health Sciences, University of York, United Kingdom.
Christian BuskeInstitute of Experimental Cancer Research, CCC Ulm, Universitäts Klinikum Ulm, Germany.
David W ScottBC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada.
Yasodha NatkunamDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Ranjana AdvaniStanford Cancer Institute, Stanford, CA, USA.
Laurie H SehnBC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada.
John RaemaekersDepartment of Hematology, Radboud UMC Nijmegen, the Netherlands.
John GribbenCentre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, United Kingdom.
Sandra LockmerDivision of Hematology, Department of Medicine, Karolinska Institute, Stockholm, Sweden.
Eva KimbyDivision of Hematology, Department of Medicine, Karolinska Institute, Stockholm, Sweden.
Marie José KerstenDepartment of Hematology, Amsterdam UMC location University of Amsterdam, Cancer Center Amsterdam, the Netherlands.
Delphine Maucort-BoulchUniversité Lyon 1, Villeurbanne, France.
Bauke YlstraDepartment of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands.
Erik van DijkDepartment of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands.
Daphne de JongDepartment of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Cancer Research UK 29685NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37038467
PMCPMC10082297

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.